The global imatinib drugs market is expected to witness moderate growth registering 7.2% CAGR during the forecast period (2022-2028). An imatinib drug is generally used to treat acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome-positive. The global imatinib drugs market is growing due to the rising prevalence of cancer as well as […]
